Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 May 8;18(5):e0285530. doi: 10.1371/journal.pone.0285530

Longitudinal association between handgrip strength, gait speed and risk of serious falls in a community-dwelling older population

Thao Pham 1, John J McNeil 1, Anna L Barker 1, Suzanne G Orchard 1, Anne B Newman 2, Catherine Robb 1, Michael E Ernst 3,4, Sara Espinoza 5,6, Robyn L Woods 1, Mark R Nelson 7, Lawrence Beilin 8, Sultana Monira Hussain 1,9,*
Editor: Mario Ulises Pérez-Zepeda10
PMCID: PMC10166501  PMID: 37155689

Abstract

Objective

Both grip strength and gait speed can be used as markers of muscle function, however, no previous study has examined them in the same population with respect to risk of falls.

Methods

In this prospective cohort study, utilising data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial and ASPREE-Fracture substudy, we analysed the association of grip strength and gait speed and serious falls in healthy older adults. Grip strength was measured using a handheld dynamometer and gait speed from 3-metre timed walks. Serious falls were confined to those involving hospital presentation. Cox regression was used to calculate hazard ratios (HR) and 95% confidence intervals (CI) for associations with falls.

Results

Over an average of 4.0±1.3 years, amongst 16,445 participants, 1,533 had at least one serious fall. After adjustment for age, sex, physical activity, body mass index, Short Form 12 (state of health), chronic kidney disease, polypharmacy and aspirin, each standard deviation (SD) lower grip strength was associated with 27% (HR 1.27, 95% CI 1.17–1.38) higher risk of falls. The results remained the same for males and females. There was a dose-response relationship in the association between grip strength and falls risk. The higher risk of falls was observed in males in all body mass index (BMI) categories, but only in obese females. The association between gait speed and falls risk was weaker than the association between grip strength and falls risk.

Conclusions

All males and only obese females with low grip strength appear to be at the greatest risk of serious falls. These findings may assist in early identification of falls.

Introduction

Falls are associated with reduced independence and are the second leading cause of death due to injury among people over 60 years of age [1]. In the United States, approximately $50 billion is spent on medical costs related to non-fatal fall injuries and $754 million on fatal falls each year [2]. In Australia, among those aged 65 years and over in 2019–20, falls resulted in over 133,000 hospitalisations and 5,000 deaths [3]. The average health system cost per fall injury in the Republic of Finland and Australia were USD3611 and USD1049, respectively [4].

Several factors can increase falls risk such as mobility impairment, loss of balance [5], older age, being female, frailty, living with chronic conditions (e.g., cardiovascular disease, diabetes, osteoarthritis), as well as medications used to treat these conditions, including polypharmacy [6]. Among these risk factors, identification of modifiable factors which influence balance such as muscle strength [7] might be important for preventing falls in older adults. Thus, a better understanding of the influences of muscle strength on falls is crucial in planning interventions to prevent falls among older adults.

In many studies, muscle strength has been measured using hand grip strength [8]. Similarly, gait speed is increasingly recognised as a measure of lower limb muscle function [5]. Previous studies have examined the association between grip strength and falls risk and reported inconclusive findings [911]. A previously published systematic review including five publications and a recent cross-sectional study showed that low gait speed is associated with increased falls risk [6, 12]. The MOBILIZE Boston Study showed that faster gait speed was associated with an increased risk of outdoor falls and slower gait speed was associated with an increased risk of indoor falls [13]. The reason for these inconclusive findings for both the associations between grip strength and falls [911] and gait speed and falls [6, 12, 13] may be due to the small sample size of these studies, differences in the study populations examined with respect to existing chronic disease and the data on falls were mostly self-reported. All studies included in the systematic review except the MOBILIZE Boston Study, examining the associations between gait speed and falls were not adjusted for confounders or only adjusted for age and sex [6, 12, 13]. Thus, it is still unclear whether grip strength and gait speed are important independent predictors of falls irrespective of distinct subclinical chronic diseases, medication use, etc. No previous study has examined the association between grip strength and gait speed in the same population, except the Osteoporotic Fractures in Men (MrOS) Study [14]. In this current study, we examined the association of hand grip strength and gait speed and serious fall-related hospital presentation in a large community-based apparently healthy older adult population, free from significant age-related diseases at baseline.

Materials and methods

Participants, design and setting

This study used data from the ASPirin in Reducing Events in the Elderly (ASPREE) and ASPREE-Fracture substudy which collected detailed information on serious falls from Australian participants. Ethics approvals were obtained from the Monash University Human Research Ethics Committee (MUHREC) for both the ASPREE principal trial and the ASPREE-Fracture substudy. Written informed consent was obtained from all participants.

ASPREE was a double-blinded, randomised, placebo-controlled primary prevention trial of aspirin that recruited 19,114 community-based older adults, between March 2010 and December 2014. ASPREE participants were free from cardiovascular disease (CVD) events, dementia, physical disability, or chronic illness expected to limit survival to less than 5 years. A total of 16,703 participants (aged ≥70 years) were recruited within Australia, and 2,411 participants (aged ≥65 years) were recruited within the United States [15, 16]. Further details regarding screening, recruitment and trial design have been published previously [16].

Hospital presentation for falls

The ASPREE-Fracture sub-study collected data on all fractures or hospital presentations resulting from a serious fall that occurred post-randomisation. A serious fall was defined as an event which resulted in a person coming to rest inadvertently on the ground or floor or other lower level and resulted in presentation to a hospital [17]. During annual in-person visits and 6-month telephone follow-up, participants were asked about hospital presentations that had occurred because of a serious fall or fracture(s) within the previous six months. All potential fractures or serious fall-related hospital presentation events were followed up by data collection from general practice, specialist, and hospital medical records. Verifying serious fall-related hospital admission was undertaken by reviewing these records and confirming the fall event date. All potential serious falls were reviewed by an endpoint adjudication committee consisting of clinicians and research personnel blinded to ASPREE treatment group allocation [18].

Demographic data and anthropometric measurements

The ASPREE principal trial collected data from in-person visits, 6-monthly telephone contacts, reviews of general practice and hospital records, and death certificates. Anthropometric data including, body mass index (BMI), physical activity (walking less than 15 minutes outside) and laboratory measurements, medical morbidities, lifestyle and socio-demographic factors, prescription medications and other health-related parameters. Modified Fried frailty phenotype, which defines frailty as the presence of weakness, slowness, exhaustion, low physical activity and weight loss, was used to categorise frailty status. Anyone with one or two criteria was categorised as prefrail, and three or more criteria were categorised as frail [19, 20].

Grip strength and gait speed

During recruitment, grip strength (kilogram force (kgf)) was measured using a handheld dynamometer in a seated position with the arm rested at 90°. A maximum of 3 measurements on each hand with a 15–20 second rest in between was recorded. The average grip strength of the dominant hand was used in this analysis. Gait speed (metre per second (m/s)) was measured from participants completing two timed walks of 3 metres at usual pace from standing start, with at least 1 metre at the end of the course to prevent slowing. The mean average of two walks was used in this analysis.

Statistical analysis

The distribution of hand grip strength showed differences between males and females (S1 Fig in S1 File). Grip strength was subsequently categorised according to sex-specific quintiles of standard deviation (SD). The categories were low grip strength (quintile 1, lowest 20%), medium grip strength (quintile 2–4, middle 60%) and high grip strength (quintile 5, highest 20%).

Initially, grip strength was treated as a continuous variable. Following that, it was treated as a categorical variable, with high grip strength as the reference category. Furthermore, the European Working Group on Sarcopenia in Older People (EWGSOP) [21] was used to examine the association between grip strength and falls. The distribution of gait speed for male and female were similar (S2 Fig in S1 File), gait speed was categorised as low gait speed (quintile 1, lowest 20%), medium gait speed (quintile 2–4, middle 60%) and high gait speed (quintile 5, highest 20%). The reference category for gait speed was high gait speed. We have checked the correlation between grip strength and gait speed by using Pearson-correlation test.

Baseline general characteristics of participants were analysed according to grip strength and gait speed categories. Analysis of variance (ANOVA) was used for continuous variables and x2 tests for categorical variables. Cox proportional hazards regression was used to calculate hazard ratio (HR) and 95% CI for hand grip strength from the time of randomisation to the first serious fall-related hospital presentation.

Analyses of grip strength and risk of falls were adjusted for a priori selected age, sex (Model 1); Model 1 and physical activity, BMI and Short Form 12 (state of health) (Model 2); Model 2 and chronic kidney disease and polypharmacy (Model 3); Model 3 and aspirin (100 mg) (Model 4). Analyses for gait speed and risk of falls were adjusted with the same covariate adjustments as grip strength, with an additional variable for walking aid in all analysis models.

We examined if age and sex or BMI and sex modified the association between grip strength and falls by examining the interaction. There was an interaction between BMI and sex (p = 0.06), and hence, stratified analyses according to BMI categories and sex were also performed in sensitivity analyses. Additionally, for grip strength analyses, we excluded frail and prefrail participants and repeated the analyses since prefrailty/frailty is associated with several adverse effects that increases the risk of falls [22]. Similarly, for gait speed, we repeated the analyses excluding those who use a walking aid.

Statistical analyses were performed using Stata MP version 17 for Windows (StataCorp LP, College Station, TX).

Results

A total of 16,445 participants were included in the grip strength analysis, including 1,512 participants that experienced at least one serious fall. A total of 16,616 participants were included in the gait speed analysis, including 1,533 participants that experienced at least one serious fall (S3 Fig in S1 File). Participants were followed up over an average of 4.0 (SD 1.3) years. The overall incidence rate of falls in our participants was 23 per 1000 person-years. There was no/mild correlation between grip strength and gait speed (Pearson-correlation coefficient = 0.25, p <0.001).

The baseline characteristics of the participants according to grip strength categories are shown in Table 1. Participants with low grip strength were less likely to engage in physical activity, more often have chronic kidney disease and more likely to be treated with multiple medications (polypharmacy) compared to those with higher grip strength. 5.3% serious falls were observed in people with high grip strength, whereas 13.7% serious falls were observed in those who had a low grip strength (Fig 1). The rate of serious falls was higher in males with a grip strength <30 kgf and female with a grip strength <20 kgf (Fig 2).

Table 1. Baseline characteristics of the included participants overall and according to categories of grip strength.

Overall High (Q5) Medium (Q2-Q4) Low (Q1) p-value
N (%) 16445 (100) 3126 (19.01) 9957 (60.55) 3362 (20.44)
Age in years 75.29 (4.36) 73.5 (3.07) 75.17 (4.14) 77.31 (5.13) <0.001
Females, n (%) 9015 (54.82) 1676 (53.61) 5495 (55.19) 1844 (54.85) 0.31
Low activity, n (%) 1049 (6.38) 145 (4.64) 609 (6.12) 295 (8.77) <0.001
BMI (kg/m 2 ) 28.00 (4.60) 28.19 (4.34) 28.00 (4.60) 27.89 (4.84) <0.001
Waist circumference (cm) 97.10 (12.68) 97.59 (12.48) 96.87 (12.61) 97.31 (13.08) 0.013
Smoking history, n (%) 0.032
    Current/Former 7307 (44.43) 1419 (45.39) 4460 (44.79) 1428 (42.47)
    Never 9138 (55.57) 1707 (54.61) 5497 (55.21) 1934 (57.53)
Alcohol use, n (%) <0.001
    Current/Former 13786 (83.83) 2679 (85.70) 8363 (83.99) 2744 (81.62)
    Never 2659 (16.17) 447 (14.30) 1594 (16.01) 618 (18.38)
SF12 (state of health),** n (%) <0.001
    Good health 15758 (95.86) 3048 (97.50) 9575 (96.20) 3135 (93.30)
    Fair/Poor health 681 (4.14) 78 (2.50) 378 (3.80) 225 (6.70)
Systolic blood pressure 139.80 (16.33) 140.06 (16.15) 139.85 (16.24) 139.41 (16.74) 0.063
Chronic kidney disease**, n (%) 3992 (26.28) 702 (24.32) 2316 (25.24) 974 (31.14) <0.001
Polypharmacy#, n (%) 4274 (26.0) 604 (19.3) 2536 (25.5) 1134 (33.7) <0.001
On trial medication (Aspirin, 100mg), n (%) 8202 (49.88) 1522 (48.69) 4985 (50.07) 1695 (50.42) 0.317
Exposure
    Grip strength (kgf) (median and IQR), males 35 (8.7, 62) 35.3 (33.3, 37) 31 (28.67, 33) 24.7 (8.7, 28.3)
    Grip strength (kgf) (median and IQR), females 20.7 (0, 40.7) 20.7 (19.7, 22.0) 18.0 (16.7, 19.3) 14.0 (0, 16.3)
Outcome
    Falls n, (%) 1512 (9.20) 164 (5.25) 890 (8.94) 459 (13.65) <0.001
    Incidence rate per 1000 person-year (95% CI) 23 (22, 24) 34 (31, 37) 23 (21, 24) 13 (11, 15)

Kgf = kilogram force; BMI = body mass index; SF12 = Short Form 12; IQR = interquartile range

*Grip strength (kgf) categories: Low (Q1, lowest 20%), Medium (Q2-Q4, middle 60%), High (Q5, highest 20%)

**SF12 (state of health): measure of self-reported health status

***Chronic kidney disease baseline: eGFR > an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m2 or a ratio of albumin (in milligrams per litre) to creatinine (in millimoles per litre) in urine of 3 or more

#Polypharmacy: the use of >5 medications

Fig 1. Distribution of grip strength (kilogram force) according to no fall vs experiencing a serious fall.

Fig 1

a) Male, b) Female.

Fig 2. Nelson-Aalen cumulative hazard estimates–incidence of serious falls according to grip strength (kilogram force) categories.

Fig 2

a) All participant, b) Male, c) Female.

The baseline characteristics of participants according to gait speed categories are shown in S1 Table in S1 File. Participants with low gait speed were less likely to engage in physical activity, have chronic kidney disease and treated with polypharmacy compared to those with high gait speed.

Associations between grip strength and risk of serious falls

Table 2 presents the association between grip strength and serious falls. In the fully adjusted model, each SD lower grip strength was associated with 27% (HR 1.27, 95% CI 1.17, 1.38) increase in risk of serious falls for all participants. In sex-stratified analysis, the results remained similar for males (HR 1.28, 95% CI 1.14, 1.44) and females (HR 1.27, 95% CI 1.12, 1.43). When risk of serious falls amongst those with high grip strength (quintile 5) was compared with the medium and low grip strength groups, the risk of serious falls increased by 47% (HR 1.47, 95% CI 1.24, 1.76) for all participants with medium grip strength (quintile 2–4) and 73% (HR 1.73, 95% CI 1.42, 2.10) for those with low grip strength (quintile 1) in the fully adjusted model. Similarly, lower grip strength increased the risk of serious falls when these analyses were stratified by sex. For males, compared with the high grip strength category (quintile 5), there was a 94% increased risk in the medium grip strength category (HR 1.94, 95% CI 1.39, 2.71) and a 2.3-fold increased risk in the low grip strength category (HR 2.30, 95% CI 1.60, 3.32). For females, there was a 31% increased risk in the medium grip strength category (HR 1.31, 95% CI 1.07, 1.61) and a 52% increased risk in the low grip strength category (HR 1.52, 95% CI 1.21, 1.92). Using the EWGSOP cut-off points for grip strength, we found similar results (S2 Table in S1 File).

Table 2. Association between grip strength and risk of falls (HR, 95% CI).

Model 1 Model 2 Model 3 Model 4
All Population (n = 16 445)
Linear association e(ach SD decrease) 1.30 (1.22, 1.43) 1.30 (1.20, 1.41) 1.27 (1.17, 1.38) 1.27 (1.17, 1.38)
Grip strength (kgf) quintiles*
    High (Q5) Ref Ref Ref Ref
    Medium (Q2-Q4) 1.44 (1.22, 1.71) 1.44 (1.21, 1.70) 1.48 (1.24, 1.76) 1.47 (1.24, 1.76)
    Low (Q1) 1.79 (1.49, 2.15) 1.75 (1.45, 2.11) 1.73 (1.42, 2.10) 1.73 (1.42, 2.10)
Stratified by sex
Males** (n = 7430)
Linear association (each SD decrease) 1.32 (1.18, 1.48) 1.30 (1.17, 1.46) 1.28 (1.14, 1.44) 1.28 (1.14, 1.44)
Grip strength (kgf) quintiles
    High (Q5) Ref Ref Ref Ref
    Medium (Q2-Q4) 1.76 (1.29, 2.40) 1.76 (1.29, 2.40) 1.94 (1.39, 2.71) 1.94 (1.39, 2.71)
    Low (Q1) 2.27 (1.62, 3.18) 2.21 (1.57, 3.11) 2.30 (1.60, 3.32) 2.30 (1.60, 3.32)
Females** (n = 9015)
Linear association (each SD decrease) 1.32 (1.18, 1.48) 1.30 (1.16, 1.46) 1.27 (1.43, 1.13,) 1.27 (1.12, 1.43)
Grip strength (kgf) quintiles
    High (Q5) Ref Ref Ref Ref
    Medium (Q2-Q4) 1.31 (1.08, 1.61) 1.31 (1.07, 1.60) 1.31 (1.07, 1.62) 1.31 (1.07, 1.61)
    Low (Q1) 1.61 (1.29, 2.01) 1.57 (1.26, 1.97) 1.53 (1.21, 1.93) 1.52 (1.21, 1.92)

Kgf = kilogram force; SD = standard deviation; Ref = reference.

Data presented as hazard ratio [HR, 95% confidence interval (CI)]. Model 1: age and gender. Model 2: age, gender, physical activity, BMI and self-reported health status. Model 3: age, gender, physical activity, BMI, SF12 (state of health), chronic kidney disease, and polypharmacy. Model 4: age, gender, physical activity, BMI, SF12 (state of health), chronic kidney disease, polypharmacy and aspirin (100mg).

*Grip strength (kgf) categories: Low (Q1, lowest 20%), Medium (Q2-Q4, middle 60%), High (Q5, highest 20%)

**Not adjusted for gender

Associations between gait speed and risk of serious falls

Table 3 presents the association between gait speed and the risk of serious falls. In the adjusted models, one SD decrease in gait speed was not associated with the risk of serious falls. However, when examined as gait speed categories, we found those in the lowest quintile of gait speed had a 48% increased risk of serious falls (HR 1.48, 95% CI 1.24, 1.77) compared with the highest quintile. Similar results were observed when males and females were compared separately i.e., males (HR 1.53, 95% CI 1.13, 2.09), females (HR 1.46, 95% CI 1.18, 1.82).

Table 3. Association between gait speed and risk of falls (HR, 95% CI).

Model 1 Model 2 Model 3 Model 4
All Population (n = 16 445)
Linear association (each SD decrease) 0.998 (0.997, 0.998) 0.998 (0.997, 0.998) 0.998 (0.997, 0.999) 0.998 (0.997, 0.999)
Gait speed (m/s) quintiles *
    High (Q5) Ref Ref Ref Ref
    Medium (Q2-Q4) 1.16 (1.00, 1.34) 1.15 (1.00, 1.34) 1.18 (1.01, 1.37) 1.18 (1.01, 1.37)
    Low Q1 1.55 (1.31, 1.83) 1.50 (1.27, 1.78) 1.48 (1.24, 1.77) 1.48 (1.24, 1.77)
Stratified by sex
Males** (n = 7430)
Linear association (each SD decrease) 0.997 (0.995, 0.998) 0.997 (0.995, 0.999) 0.997 (0.996, 0.999) 0.997 (0.996, 0.999)
Gait speed (m/s) quintiles *
    High (Q5) Ref Ref Ref Ref
    Medium (Q2-Q4) 1.27 (0.98, 1.65) 1.23 (0.95, 1.60) 1.26 (0.96, 1.65) 1.26 (0.96, 1.65)
    Low (Q1) 1.71 (1.28, 2.29) 1.56 (1.16, 2.10) 1.53 (1.13, 2.09) 1.53 (1.13, 2.09)
Females** (n = 9015)
Linear association (each SD decrease) 0.998 (0.997, 0.999) 0.998 (0.997, 0.999) 0.998 (0.997, 1.000) 0.998 (0.997, 1.000)
Gait speed (m/s) quintile *
    High (Q5) Ref Ref Ref Ref
    Medium (Q2-Q4) 1.10 (0.92, 1.32) 1.12 (0.94, 1.34) 1.14 (0.95, 1.37) 1.14 (0.95, 1.37)
    Low (Q1) 1.47 (1.20, 1.81) 1.48 (1.20, 1.83) 1.46 (1.18, 1.82) 1.46 (1.18, 1.82)

m/s = metre per second; SD = standard deviation; Ref = reference.

Data presented as hazard ratio [HR, 95% confidence interval (CI)]. Model 1: age, gender, and walking aid. Model 2: age, gender, walking aid, physical activity, BMI and SF12 (state of health). Model 3: age, gender, walking aid, physical activity, BMI, SF12 (state of health), chronic kidney disease, and polypharmacy. Model 4: age, gender, walking aid, physical activity, BMI, SF12 (state of health), chronic kidney disease, polypharmacy and aspirin (100mg).

*Gait speed (m/s) categories: Low (Q1, lowest 20%), Medium (Q2-Q4, middle 60%), High (Q5, highest 20%)

**Not adjusted for gender

Sensitivity analyses

The association between grip strength and the risk of serious falls according to BMI categories are presented in S4 Table in S1 File. Amongst overweight males, one SD lower grip strength increased the risk of serious falls by 33% (HR 1.33, 95% CI 1.11, 1.58). Similarly, in obese males, one SD lower grip strength increased the risk of serious falls by 35% (HR 1.35, 95% CI 1.10, 1.65). When grip strength was analysed as categorical variables, high risk of serious falls was observed in those with medium and low grip strength amongst overweight and obese males. In contrast, in normal weight and overweight females, lower grip strength was not associated with serious falls risk. Only obese females with a lower hand grip strength had an increased risk of serious falls. For example, one SD lower grip strength increased the risk of serious falls by 47% (HR 1.47, 95% CI 1.19, 1.82). When grip strength was analysed as a categorical variable, those with low grip strength had an increased risk of serious falls by 94% (HR 1.94, 95% CI 1.26, 2.98) compared to those with high grip strength.

The associations between grip strength and serious falls persisted when we excluded the participants who were prefrail/frail (n = 6300) (S3 Table in S1 File). The associations between gait speed and risk of serious falls persisted when excluding participants who use a walking aid (n = 364) (S5 Table in S1 File).

Discussion

The principal finding of this study was that a lower hand grip strength in older adults was associated with a substantially increased risk of serious falls, resulting in hospital presentation. There was a dose-response relationship in the association between grip strength and risk of serious falls such that the lower the grip strength, the higher the risk of serious falls. When the analyses were stratified by BMI categories, the risk of serious falls was increased in males irrespective of BMI categories. However, the increased risk of serious falls in females was mainly confined in the obese BMI category. A low gait speed was also predictive of serious falls but with a weaker relationship than grip strength. Furthermore, the association between gait speed and serious falls was confined only among participants who were in the lowest gait speed category, but not in the middle gait speed category.

Our finding that decreasing hand grip strength is a risk factor for serious falls are in agreement with studies previously published [9, 10, 2327]. However, most of the previously published studies were cross-sectional [2327] except for the Tasmanian Older Adult Cohort (TASOAC) study [9] and a cohort study of Brazilian women aged 60 years and over [10]. There are several differences between ASPREE and TASOAC. For example, TASOAC participants were younger (51.1–79.9 years of age), and pre-existing illnesses were not excluded. In addition, falls risk at 10 years was assessed using the Short Form Physiological Profile Assessment [9], actual falls were not recorded. The analyses were adjusted for age only [9] but several risk factors are associated with falls [6]. Similarly, the Brazilian study had several limitations as falls were self-reported and the participants were not free from subclinical diseases [10]. Our finding was inconsistent with the Korean Longitudinal Study of Aging (KLoSA), where grip strength was not associated with the risk of falls [11]. Perhaps in this study, participants did not show variations in grip strength, since 39% of the study participants had cognitive decline/dementia, and 18.5% participants had physical disability. The number of participants with frailty and prefrailty was not mentioned [11]. This study also used self-reported fall events [11].

Our study extends beyond the TASOAC and the Brazilian women’s study as we included a larger population (TASOAC vs Brazilian women’s study vs ASPREE: 1,041 vs 195 vs 16,445), including both sexes, initially relatively healthy population and adjusted for several risk factors: age, gender, physical activity, BMI, Short Form 12 (state of health), chronic kidney disease, polypharmacy and aspirin (100mg). The TASOAC study also failed to identify the difference in grip strength between males and females. In contrast, the ASPREE females had lower grip strength than males, which is supported by other studies that females have lower average hand grip strength than males [28].

In stratified analyses by BMI category, we found that the risk of serious falls increased in males irrespective of BMI category. In females, the risk of falls was confined mainly to those who were obese. These analyses demonstrate a new finding and may be explained by the different characteristics of body composition and grip strength in males and females [29]. Sarcopenic obesity is more common in older females than males [30]. Furthermore, on average, grip strength for males decreases faster with age than it does for females [27]. The gender difference tends to narrow slightly with older age [31].

A potential explanation of these findings was that low grip strength is an indicator of frailty which, in turn, is a risk factor for serious falls amongst ageing individuals [32]. However, in sensitivity analyses, we have excluded participants who were prefrail or frail and found a similar relationship. This finding suggests that grip strength reflects muscle strength more generally which in turn is a major determinant of serious falls risk within this population. Low muscle strength has been shown to be associated with worse dynamic balance, higher fear of falling, and the occurrence of falls over the previous year [33], which are predictors of future falls [4, 34, 35].

We found a weaker association between lower gait speed and serious falls than with lower grip strength and serious falls. Whereas previous studies showed that low gait speed is common in people who experienced a fall or it increases incidence of falls [6, 12]. These studies have methodological differences than the current study in regards to sample size [6, 12, 13], confounding adjustment [6, 12], outcome measurement [6, 12] etc. The contrasting findings from these studies can be due to differences in how gait speed was measured. In the previous studies, participants were required to walk 8–10 meters for gait speed measurement [6, 12, 13]. Whereas in this current study, participants were required to walk 3 meters. Another possibility could be slower walkers are more likely to be less active and/or cautious during daily activities.

The strength of our study includes its large sample size, intensive data collection from in-person visits, telephone assessments, rigorous collection of relevant ancillary information, and thorough objective assessment of hand grip strength and gait speed. Falls were verified by reviewing clinical records that were then adjudicated to ensure robust case ascertainment. Our results need to be considered within the study’s limitations. This analysis is a post-hoc analysis of data collected as part of a clinical trial; thus, its findings may have arisen by chance, although the internal consistency of the findings makes this less likely. Lastly, the definition of serious falls required a hospital presentation, which may have underestimated the overall number of falls.

Conclusion

The clinical implications of these findings are that the measurement of hand grip strength can provide a simple and objective way of identifying older adults with a greater likelihood of having a serious fall. Based on this study, all males and obese females with low grip strength appear to be at the greatest risk for serious falls. The early identification of these most susceptible individuals would enable targeted prevention strategies, that may include muscle strengthening through resistance exercise [36], to reduce risk of serious falls in older populations.

Supporting information

S1 File

(DOCX)

Acknowledgments

We thank the patients who participated in this trial.

Data Availability

Data contain potentially sensitive patient information. However, data request may be sent to Monash University using the following email address aspree.ams@monash.edu.

Funding Statement

Source of Funding: The ASPirin in Reducing Events in the Elderly (ASPREE) study was supported by grants from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health (U01AG029824); the National Health and Medical Research Council of Australia (334037 and 1127060); Monash University (Melbourne, VIC, Australia); and the Victorian Cancer Agency (Australia). The ASPREE-Falls & Fractures sub-study was supported by a grant from the National Health and Medical Research Council of Australia (1067242). Role of the Funder/Sponsor: The sponsor had no role in the design and conduct of this study; collection, management, analysis, and interpretation of the data and decision to submit the manuscript for publication but was given the opportunity to review and comment on the manuscript.

References

  • 1.Organisation WH. WHO Global Report on Falls Prevention in Older Age. 2021. [Google Scholar]
  • 2.Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical Costs of Fatal and Nonfatal Falls in Older Adults. J Am Geriatr Soc. 2018;66(4):693–8. doi: 10.1111/jgs.15304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Australian Institute of Health and Welfare (2022) Falls in older Australians 2019–20: hospitalisations and deaths among people aged 65 and over, AIHW, Australian Government, accessed 20 May 2022.
  • 4.Lee S, Oh E, Hong G-RS. Comparison of Factors Associated with Fear of Falling between Older Adults with and without a Fall History. International journal of environmental research and public health. 2018;15(5):982. doi: 10.3390/ijerph15050982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Komforti D, Joffe C, Magras A, Peller A, Garbe E, Garib R, et al. Does skeletal muscle morphology or functional performance better explain variance in fast gait speed in older adults? Aging Clinical and Experimental Research. 2021;33(4):921–31. doi: 10.1007/s40520-020-01596-y [DOI] [PubMed] [Google Scholar]
  • 6.Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology (Cambridge, Mass). 2010;21(5):658–68. doi: 10.1097/EDE.0b013e3181e89905 [DOI] [PubMed] [Google Scholar]
  • 7.Granacher U, Gollhofer A, Hortobágyi T, Kressig RW, Muehlbauer T. The importance of trunk muscle strength for balance, functional performance, and fall prevention in seniors: a systematic review. Sports Med. 2013;43(7):627–41. doi: 10.1007/s40279-013-0041-1 [DOI] [PubMed] [Google Scholar]
  • 8.McGrath R, Johnson N, Klawitter L, Mahoney S, Trautman K, Carlson C, et al. What are the association patterns between handgrip strength and adverse health conditions? A topical review. SAGE Open Med. 2020;8:2050312120910358. doi: 10.1177/2050312120910358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Balogun S, Winzenberg T, Wills K, Scott D, Jones G, Aitken D, et al. Prospective Associations of Low Muscle Mass and Function with 10-Year Falls Risk, Incident Fracture and Mortality in Community-Dwelling Older Adults. J Nutr Health Aging. 2017;21(7):843–8. doi: 10.1007/s12603-016-0843-6 [DOI] [PubMed] [Google Scholar]
  • 10.Neri SGR, Lima RM, Ribeiro HS, Vainshelboim B. Poor handgrip strength determined clinically is associated with falls in older women. J Frailty Sarcopenia Falls. 2021;6(2):43–9. doi: 10.22540/JFSF-06-043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kim YS, Yao Y, Lee SW, Veronese N, Ma SJ, Park YH, et al. Association of frailty with fall events in older adults: A 12-year longitudinal study in Korea. Arch Gerontol Geriatr. 2022;102:104747. doi: 10.1016/j.archger.2022.104747 [DOI] [PubMed] [Google Scholar]
  • 12.Štefan L, Kasović M, Zvonar M. Gait Speed as a Screening Tool for Foot Pain and the Risk of Falls in Community-Dwelling Older Women: A Cross-Sectional Study. Clin Interv Aging. 2020;15:1569–74. doi: 10.2147/CIA.S260931 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Quach L, Galica AM, Jones RN, Procter-Gray E, Manor B, Hannan MT, et al. The nonlinear relationship between gait speed and falls: the Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston Study. J Am Geriatr Soc. 2011;59(6):1069–73. doi: 10.1111/j.1532-5415.2011.03408.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Winger ME, Caserotti P, Cauley JA, Boudreau RM, Piva SR, Cawthon PM, et al. Lower Leg Power and Grip Strength are Associated with Increased Fall Injury Risk in Older Men: the Osteoporotic Fractures in Men (MrOS) Study. J Gerontol A Biol Sci Med Sci. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, et al. Effect of Aspirin on Disability-free Survival in the Healthy Elderly. The New England journal of medicine. 2018;379(16):1499–508. doi: 10.1056/NEJMoa1800722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemporary clinical trials. 2013;36(2):555–64. doi: 10.1016/j.cct.2013.09.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Barker AL, McNeil JJ, Seeman E, Ward SA, Sanders KM, Khosla S, et al. A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy. Injury prevention: journal of the International Society for Child and Adolescent Injury Prevention. 2016;22(4):297–301. doi: 10.1136/injuryprev-2015-041655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hussain SM, Ernst ME, Barker AL, Margolis KL, Reid CM, Neumann JT, et al. Variation in Mean Arterial Pressure Increases Falls Risk in Elderly Physically Frail and Prefrail Individuals Treated With Antihypertensive Medication. Hypertension. 2022:101161hypertensionaha12219356. doi: 10.1161/HYPERTENSIONAHA.122.19356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56. doi: 10.1093/gerona/56.3.m146 [DOI] [PubMed] [Google Scholar]
  • 20.Wolfe R, Murray AM, Woods RL, Kirpach B, Gilbertson D, Shah RC, et al. The aspirin in reducing events in the elderly trial: Statistical analysis plan. Int J Stroke. 2018;13(3):335–8. doi: 10.1177/1747493017741383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi: 10.1093/ageing/afy169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. doi: 10.1016/S0140-6736(12)62167-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Máximo RdO, Santos JLF, Perracini MR, Oliveira Cd, Duarte YAdO, Alexandre TdS. Abdominal obesity, dynapenia and dynapenic-abdominal obesity as factors associated with falls. Braz J Phys Ther. 2019;23(6):497–505. doi: 10.1016/j.bjpt.2018.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Northridge ME, Nevitt MC, Kelsey JL. Non-syncopal falls in the elderly in relation to home environments. Osteoporos Int. 1996;6(3):249–55. doi: 10.1007/BF01622742 [DOI] [PubMed] [Google Scholar]
  • 25.Davis JW, Ross PD, Nevitt MC, Wasnich RD. Risk factors for falls and for serious injuries on falling among older Japanese women in Hawaii. J Am Geriatr Soc. 1999;47(7):792–8. doi: 10.1111/j.1532-5415.1999.tb03834.x [DOI] [PubMed] [Google Scholar]
  • 26.Schwartz AV, Villa ML, Prill M, Kelsey JA, Galinus JA, Delay RR, et al. Falls in older Mexican-American women. J Am Geriatr Soc. 1999;47(11):1371–8. [PubMed] [Google Scholar]
  • 27.Arvandi M, Strasser B, Volaklis K, Ladwig KH, Grill E, Matteucci Gothe R, et al. Mediator Effect of Balance Problems on Association Between Grip Strength and Falls in Older Adults: Results From the KORA-Age Study. Gerontol Geriatr Med. 2018;4:2333721418760122. doi: 10.1177/2333721418760122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Leyk D, Gorges W, Ridder D, Wunderlich M, Rüther T, Sievert A, et al. Hand-grip strength of young men, women and highly trained female athletes. Eur J Appl Physiol. 2007;99(4):415–21. doi: 10.1007/s00421-006-0351-1 [DOI] [PubMed] [Google Scholar]
  • 29.Srikanthan P, Horwich TB, Calfon Press M, Gornbein J, Watson KE. Sex Differences in the Association of Body Composition and Cardiovascular Mortality. J Am Heart Assoc. 2021;10(5):e017511. doi: 10.1161/JAHA.120.017511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wagenaar CA, Dekker LH, Navis GJ. Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: The lifelines cohort study. Clin Nutr. 2021;40(6):4422–9. doi: 10.1016/j.clnu.2021.01.005 [DOI] [PubMed] [Google Scholar]
  • 31.Sternäng O, Reynolds CA, Finkel D, Ernsth-Bravell M, Pedersen NL, Dahl Aslan AK. Factors associated with grip strength decline in older adults. Age Ageing. 2015;44(2):269–74. doi: 10.1093/ageing/afu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Duarte GP, Santos JLF, Lebrão ML, Duarte YAO. Relationship of falls among the elderly and frailty components. Rev Bras Epidemiol. 2019;21Suppl 02(Suppl 02):e180017. [DOI] [PubMed] [Google Scholar]
  • 33.Gadelha AB, Neri SGR, Nóbrega OT, Pereira JC, Bottaro M, Fonsêca A, et al. Muscle quality is associated with dynamic balance, fear of falling, and falls in older women. Exp Gerontol. 2018;104:1–6. doi: 10.1016/j.exger.2018.01.003 [DOI] [PubMed] [Google Scholar]
  • 34.Cattaneo D, Jonsdottir J, Coote S. Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network. Int J MS Care. 2014;16(4):198–202. doi: 10.7224/1537-2073.2014-062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Al-Aama T. Falls in the elderly: spectrum and prevention. Can Fam Physician. 2011;57(7):771–6. doi: 10.1136/bmj.b3692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lee R. The CDC’s STEADI Initiative: Promoting Older Adult Health and Independence Through Fall Prevention. Am Fam Physician. 2017;96(4):220–1. doi: 10.1093/geront/gnw074 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mario Ulises Pérez-Zepeda

31 Jan 2023

PONE-D-23-00361Longitudinal association between handgrip strength, gait speed and risk of serious falls in a community-dwelling older populationPLOS ONE

Dear Dr. Hussain,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mario Ulises Pérez-Zepeda, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“Source of Funding: The ASPirin in Reducing Events in the Elderly (ASPREE) study was supported by grants from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health (U01AG029824); the National Health and Medical Research Council of Australia (334037 and 1127060); Monash University (Melbourne, VIC, Australia); and the Victorian Cancer Agency (Australia).  The ASPREE-Falls & Fractures sub-study was supported by a grant from the National Health and Medical Research Council of Australia (1067242).

Role of the Funder/Sponsor: The sponsor had no role in the design and conduct of this study; collection, management, analysis, and interpretation of the data and decision to submit the manuscript for publication but was given the opportunity to review and comment on the manuscript.

Additional Contributions: We thank the patients who participated in this trial.

Conflict of Interest

Dr Hussain is the recipient of National Health and Medical Research Council (NHMRC) Early Career Fellowship (APP1142198), Professor McNeil is supported through an NHMRC Leadership Fellowship (IG 1173690). No other disclosures are reported by the other authors."

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

‘Source of Funding: The ASPirin in Reducing Events in the Elderly (ASPREE) study was supported by grants from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health (U01AG029824); the National Health and Medical Research Council of Australia (334037 and 1127060); Monash University (Melbourne, VIC, Australia); and the Victorian Cancer Agency (Australia).  The ASPREE-Falls & Fractures sub-study was supported by a grant from the National Health and Medical Research Council of Australia (1067242).

Role of the Funder/Sponsor: The sponsor had no role in the design and conduct of this study; collection, management, analysis, and interpretation of the data and decision to submit the manuscript for publication but was given the opportunity to review and comment on the manuscript.

Conflict of Interest

Dr Hussain is the recipient of National Health and Medical Research Council (NHMRC) Early Career Fellowship (APP1142198), Professor McNeil is supported through an NHMRC Leadership Fellowship (IG 1173690). No other disclosures are reported by the other authors.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in your Competing Interests section: 

“No conflict of interests was declared by any of the authors.”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this prospective cohort study, utilising data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial and ASPREE-Fracture substudy, the authors analysed the association of grip strength and gait speed and serious falls in healthy older adults. They found that all males and only obese females with low grip strength appeared to be at the

greatest risk of serious falls. This may assist in early identification of falls. Limitations of this observational study are sufficiently acknowledged.

Reviewer #2: This is an interesting manuscript that evaluates the association between the handgrip strength, gait speed and risk of serious falls in a community-dwelling older population. The authors found that handgrip strength was associated with risk of falls in both genders. One SD lower of grip strength was associated with 27% higher risk of falls. The association between gait speed and risk of falls was not as significant as grip strength. However, there are some points that should be addressed in this manuscript.

1. There are absolute cu-off points for grip strength and gait speed among elderly population – it would be more interesting to evaluate the association with normal or abnormal grip strength and gait speed on the risk of falls.

2. For Table 2 and 3 – the data were presented with gender-specification but the gender variable was still put into the models.

3. The results will be more informative if it is segregated by grip strength and gait speed – for example, there could be four matrixes with normal or abnormal grip strength or gait speed – then to evaluate the risk of falls among these four different situations .

4. Since this is a longitudinal study – the participants were measured every 6 months or one year – how about using the repeated measure analyses to evaluate the associations.

5. This study examines the associations among community-dwelling older population. However, there are more than 20% subjects with polypharmacy and multiple chronic diseases. It would be more informative if the chronic diseases and medications status could be present in the Table 1.

6. There are some studies using appendicular muscle mass rather than BMI or body fat to examine the association between sarcopenia, frailty and disability among elderly population in recently.

7. There are some important factors such as the dietary pattern, physical activity and lifestyle could be potential confounders to evaluate the associations.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 May 8;18(5):e0285530. doi: 10.1371/journal.pone.0285530.r002

Author response to Decision Letter 0


7 Apr 2023

Reviewers’ comments

Reviewer #1:

In this prospective cohort study, utilising data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial and ASPREE-Fracture substudy, the authors analysed the association of grip strength and gait speed and serious falls in healthy older adults. They found that all males and only obese females with low grip strength appeared to be at the greatest risk of serious falls. This may assist in early identification of falls. Limitations of this observational study are sufficiently acknowledged.

Author response: We appreciate your feedback and insight into our analyses.

Reviewer #2:

1. There are absolute cut-off points for grip strength and gait speed among elderly population – it would be more interesting to evaluate the association with normal or abnormal grip strength and gait speed on the risk of falls.

Author Response: The ASPREE study participants are initially healthy older aged >70 years. Grip strength varies according to age [1]. Furthermore, a meta-analysis on grip strength by Dodds RM et al [2] found variation in grip strength for different countries, and highlighted the need for geographical cut-off points for grip strength. Therefore, we decided to categorise grip strength and gait speed for the ASPREE population.

However, as the reviewer suggested we compared our findings with the established cut-off points for grip strength and gait speed. The European Working Group on Sarcopenia in Older People (EWGSOP) [3] cut-off points were derived from people living in Europe. Since ASPREE participants resembles mostly with this population, we compared the grip strength and gait speed to ASPREE participants with EWGSOP.

Grip Strength: The absolute grip strength cut-off points for EWGSOP are similar with the ASPREE categories. EWGSOP categories were: females; normal ≥16 kgf, abnormal <16 kgf and males; normal ≥27 kgf; abnormal <27 kgf. ASPREE category cut-off points were: female Q1 14.0 kgf (median), Q2 18.0 kgf, Q3 20.7 kgf and male Q1 24.7 kgf, Q2 31.0 kgf, Q3 35.3 kgf.

If we apply EWGSOP categories in ASPREE the results look similar to the results presented in the manuscript. The results are presented in the following table.

Table: Association between grip strength and risk of falls (HR, 95% CI) using European Working Group on Sarcopenia in Older People (EWGSOP) cut-off points for grip strength

Model 1 Model 2 Model 3 Model 4

Males (n=7430)

For all (each SD decrease) 1.32 (1.18, 1.48) 1.30 (1.17, 1.46) 1.28 (1.14, 1.44) 1.28 (1.14, 1.44)

Grip strength (kgf) as categorical variable

Normal Ref Ref Ref Ref

Low 1.45 (1.17, 1.79) 1.43 (1.15, 1.77) 1.35 (1.08, 1.69) 1.35 (1.08, 1.69)

Females (n= 9015)

For all (each SD decrease) 1.32 (1.18, 1.48) 1.30 (1.16, 1.46) 1.27 (1.43, 1.13,) 1.27 (1.12, 1.43)

Grip strength (kgf) as categorical variable

Normal Ref Ref Ref Ref

Low 1.28 (1.11, 1.48) 1.25 (1.08, 1.45) 1.21 (1.04, 1.40) 1.20 (1.04, 1.40)

Kgf = kilogram force; SD = standard deviation; Ref = reference.

Data presented as hazard ratio [HR, 95% confidence interval (CI)]. Model 1: age and gender. Model 2: age, physical activity, BMI and self-reported health status. Model 3: age, gender, physical activity, BMI, SF12 State of health, chronic kidney disease, and polypharmacy. Model 4: age, gender, physical activity, BMI, SF12 State of health, chronic kidney disease, polypharmacy and aspirin (100mg).

*Grip strength (kgf) categories: females; normal ≥16 kgf, low <16 kfg. males; normal ≥27 kgf; low <27 kgf

Since the ASPREE population was relatively healthy, targeted interventions such as resistance exercise can assist individuals to aim for higher grip strength [4], we felt that even participants in Q1 can be targeted to aim for a grip strength like Q3−Q4.

Author Action: We have added the following line in the statistical analysis section (page 7, paragraph 144)

Furthermore, the European Working Group on Sarcopenia in Older People (EWGSOP) [21] was used to examine the association between grip strength and falls.

We have added the following line in the results section (page 11, paragraph 228)

Using the European Cut-Off points for grip strength, we found similar results (S2 Table).

Gait speed: The absolute cut-off point for EWGSOP low gait speed is ≤0.8 m/s for female and male. The ASPREE participants gait speed cut-off points are similar to EWGSOP where female is Q1 ≤0.738 m/s, Q2-4 ≤0.893 m/s and Q5 ≤1.000 m/s. For ASPREE males, Q1 ≤0.814 m/s, Q2-4 ≤0.951 m/s and Q5 ≤1.052 m/s. Thus, reanalysis is not required for gait speed.

2. For Table 2 and 3 – the data were presented with gender-specification but the gender variable was still put into the models.

Author response: We have included a foot note in Table 2 and 3 that the gender variable was not included into the models for gender-specific findings.

Author action: not applicable

3. The results will be more informative if it is segregated by grip strength and gait speed – for example, there could be four matrixes with normal or abnormal grip strength or gait speed – then to evaluate the risk of falls among these four different situations.

Author response: We have performed the analysis as per the reviewer’s suggestion. However, we decided not to present these findings because the risk of falls in the low grip strength, slow gait speed and low grip strength and slow gait speed groups were similar. The HRs and 95% CIs are presented in the table below.

Table: Association between grip strength and gait speed categories and risk of falls in all population (HR, 95% CI)

Grip strength and gait speed categories HR (95% CI)

Neither low grip strength or low gait speed (Q4-5 grip, Q4-5 gait) Reference

Low grip strength only and normal gait speed (Q1 grip, Q4-5 gait) 1.38 (1.19, 1.59)

Low gait speed only and normal grip strength (Q4-5 grip, Q1 gait) 1.46 (1.25, 1.69)

Both low grip strength and low gait speed (Q1 grip, Q1 gait) 1.38 (1.14, 1.67)

Adjusted for age, gender, physical activity, BMI, SF12 State of health, chronic kidney disease, polypharmacy and aspirin (100mg).

The measurement of grip strength is more reliable due to consistency with the dynamometer measurement tools [5]. The limitation of gait speed is the variability of gait speed measurements such as hip joint degeneration [6], fear of falling [7] and requiring at least 4-m walking pathway in a clinic for gait speed measurement [3]. Thus, our study suggests that grip strength and gait speed are equally good at identifying falls and only grip strength can be evaluated to identify people at risk.

Author action: Not applicable.

4. Since this is a longitudinal study – the participants were measured every 6 months or one year – how about using the repeated measure analyses to evaluate the associations.

Author response: In this study we aimed to answer the question if different levels of grip strength and gait speeds are associated with increased risk of falls or not. We did not aim to examine the trajectory of grip strength or the longitudinal grip strength.

Author action: not applicable

5. This study examines the associations among community-dwelling older population. However, there are more than 20% subjects with polypharmacy and multiple chronic diseases. It would be more informative if the chronic diseases and medications status could be present in the Table 1.

Author response: The ASPREE population were initially healthy and absent of chronic illness expected to limit survival to less than 5 years. Our data shows that 20% of participants were on polypharmacy. Polypharmacy in ASPREE was defined as using ≥3 prescribed medications for any reason. The common reason for the use of medications in our population was to control high blood pressure, high blood sugar or use of statins. For some conditions i.e. high blood pressure, high blood sugar, individuals may take >1 medication.

We have reported the prevalence of all the risk factors the participants had and if they were on ≥3 medications (polypharmacy).

Author action: not applicable

6. There are some studies using appendicular muscle mass rather than BMI or body fat to examine the association between sarcopenia, frailty and disability among elderly population in recently.

Author response: We do not have the measurements on appendicular mass. Furthermore, for this study, our aim was to understand the association of hand grip strength and gait speed and serious fall-related hospital presentation among elderly population, not to examine the association between appendicular mass and falls.

Author action: not applicable

7. There are some important factors such as the dietary pattern, physical activity and lifestyle could be potential confounders to evaluate the associations.

Author response: We do not have data on dietary pattern, and lifestyle. But we have data on physical activity. In our analyses we have adjusted for physical activity.

Author action: not applicable

References:

1. Frederiksen H, Hjelmborg J, Mortensen J et al. Age Trajectories of Grip Strength: Cross-Sectional and Longitudinal Data Among 8,342 Danes Aged 46 to 102. Ann. Epidemiol. 2006;16(7):554-562.

2. Dodds RM, Syddal HE, Cooper R et al. Global variation in grip strength: a systematic review and meta-analysis of normative data. Age Ageing. 2016;45(2):209-16

3. Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31

4. Lee R. The CDC's STEADI Initiative: Promoting Older Adult Health and Independence Through Fall Prevention. Am Fam Physician. 2017;96(4):220-1.

5. Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011 Jul;40(4):423-9.

6. Tateuchi H, Koyama Y, Tsukagoshi R, Akiyama H, Goto K, So K, Kuroda Y, Ichihashi N. Associations of radiographic degeneration and pain with daily cumulative hip loading in patients with secondary hip osteoarthritis. J Orthop Res. 2016 Nov;34(11):1977-1983.

7. Asai T, Misu S, Sawa R, Doi T, Yamada M. The association between fear of falling and smoothness of lower trunk oscillation in gait varies according to gait speed in community-dwelling older adults. J Neuroeng Rehabil. 2017 Jan 19;14(1):5.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Mario Ulises Pérez-Zepeda

26 Apr 2023

Longitudinal association between handgrip strength, gait speed and risk of serious falls in a community-dwelling older population

PONE-D-23-00361R1

Dear Dr. Hussain,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mario Ulises Pérez-Zepeda, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mario Ulises Pérez-Zepeda

29 Apr 2023

PONE-D-23-00361R1

Longitudinal association between handgrip strength, gait speed and risk of serious falls in a community-dwelling older population

Dear Dr. Hussain:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mario Ulises Pérez-Zepeda

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    Data contain potentially sensitive patient information. However, data request may be sent to Monash University using the following email address aspree.ams@monash.edu.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES